^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

aminoflavone Prodrug (AFP-464)

i
Other names: AFP-464
Associations
Trials
Company:
Kirax
Drug class:
Apoptosis stimulant
Associations
Trials
over1year
Systematic pan-cancer analysis identifies cGAS as an immunological and prognostic biomarker. (PubMed, Ann Transl Med)
Finally, mithramycin, MI219, AFP464, aminoflavone, kahalide F, AT13387, doxorubicin, and other drugs increased the sensitivity of cGAS expression. This study discovered that SARS-CoV-2-infected cancer patients might experience changes in their tumor environment as a result of cGAS, making patients with tumors expressing high cGAS more susceptible to COVID-19 and possibly a worsening prognosis. Furthermore, cGAS may be a novel biomarker for diagnosing and treating COVID-19-infected tumor patients.
Journal • Tumor mutational burden • Pan tumor
|
TMB (Tumor Mutational Burden) • MSI (Microsatellite instability) • CGAS (Cyclic GMP-AMP Synthase)
|
doxorubicin hydrochloride • onalespib (AT13387) • aminoflavone Prodrug (AFP-464)
over4years
New Treatments in Renal Cancer: The AhR Ligands. (PubMed, Int J Mol Sci)
Kidney cancer rapidly acquires resistance to antiangiogenic agents, such as sunitinib, developing an aggressive migratory phenotype (facilitated by c-Metsignal transduction)...Currently, there are two antitumor agent AhR ligands, with activity against renal cancer, that have been tested clinically: aminoflavone (AFP 464, NSC710464) and the benzothiazole (5F 203) prodrug Phortress...Current investigations are focused on the development of nano-delivery vehicles, apoferritin-encapsulated benzothiazoles 5F 203 and GW610, for the treatment of renal cancer. These compounds have shown improved antitumor effects against TK-10 cells in vitro at lower concentrations compared with a naked agent.
Review • Journal
|
MET (MET proto-oncogene, receptor tyrosine kinase) • AHR (Aryl hydrocarbon receptor)
|
sunitinib • aminoflavone Prodrug (AFP-464)